Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL

Chronic kidney disease is associated with adverse outcomes among patients with established cardiovascular disease (CVD) or diabetes. Commonly used medications to treat CVD are less effective among patients with reduced kidney function. METHODS: REDUCE-IT (Reduction of Cardiovascular Events with Icos...

Descripción completa

Detalles Bibliográficos
Autores principales: Majithia, Arjun, Bhatt, Deepak L., Friedman, Allon N., Miller, Michael, Steg, Ph. Gabriel, Brinton, Eliot A., Jacobson, Terry A., Ketchum, Steven B., Juliano, Rebecca A., Jiao, Lixia, Doyle, Ralph T., Granowitz, Craig, Budoff, Matthew, Preston Mason, R., Tardif, Jean-Claude, Boden, William E., Ballantyne, Christie M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614567/
https://www.ncbi.nlm.nih.gov/pubmed/34706555
http://dx.doi.org/10.1161/CIRCULATIONAHA.121.055560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614567/
https://www.ncbi.nlm.nih.gov/pubmed/34706555
http://dx.doi.org/10.1161/CIRCULATIONAHA.121.055560

Ejemplares similares